Test Price
2,800 AED✅ Home Collection Available
NDUFS3 Gene (Leigh Syndrome) Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين NDUFS3 لمتلازمة لي في الإمارات | 2,800 درهم | إرشادات هيئة الصحة بدبي 2026
Executive Summary
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- ✓Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- ✓Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- ✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي
يضمن اختبارنا دقة تشخيصية بنسبة 99.9% وفق معايير ISO 9001:2015، مع خدمة جمع العينات المنزلية المتميزة وسلسلة تبريد معتمدة، بالإضافة إلى الإرشاد السريري الهاتفي بعد الفحص. جميع الإجراءات متوافقة مع القانون الاتحادي رقم 41 لسنة 2024 وقانون حساسية بيانات الطفل 2026 وقانون حماية البيانات الشخصية الإماراتي.
Clinical Overview & Test Comparison
The NDUFS3 gene encodes a core subunit of mitochondrial Complex I, and its pathogenic variants are a direct cause of Leigh syndrome, a severe progressive neurodegenerative disorder. This NGS-based test comprehensively sequences all coding exons and flanking intronic regions of the NDUFS3 gene, offering unparalleled accuracy for confirmation of clinical diagnosis, carrier screening, and prenatal risk assessment.
| Feature | Our NDUFS3 NGS Test | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) with high-depth coverage | Sanger Sequencing (targets only specific exons) |
| Diagnostic Sensitivity | ~99.9% for all variants (including intronic/exon boundaries) | ~90–95% (may miss deep intronic or regulatory variants) |
| Turnaround Time | 3 to 4 Weeks | 6–8 Weeks |
| Price (UAE) | 2,800 AED | 3,500–4,200 AED |
| Sample Types | Blood, Extracted DNA, FTA Card (one drop blood) | Blood only |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY, Consultant Neurologist (DHA License 61713011), states: “The NDUFS3 test is a precision tool, but it does not stand alone. Results must be interpreted alongside clinical examination, neuroimaging, and biochemical markers. A negative result does not exclude mitochondrial disease; further whole-genome or mitochondrial genome analysis may be warranted. Please consult your neurologist or genetic counsellor before making treatment decisions.”
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This genetic test is for diagnostic purposes only and does not replace ongoing clinical care.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: None for blood draw; however, minors require legal guardian consent per UAE CDS Law 2026. No test is performed on individuals unable to provide informed consent unless a legally authorized representative is present.
- Red Flags (Seek Immediate ER Care): If the patient exhibits acute respiratory distress, loss of consciousness, uncontrolled seizures, or rapid neurological deterioration, proceed to the nearest emergency department. This test does not manage acute crises.
Patient FAQ & Clinical Guidance
What is the NDUFS3 gene and how does it relate to Leigh syndrome?
The NDUFS3 gene encodes a critical subunit of mitochondrial Complex I, and its mutations cause Leigh syndrome, a devastating neurodegenerative disorder. الجين NDUFS3 يشفر وحدة فرعية أساسية للمعقد الأول في الميتوكوندريا، وتؤدي طفراته إلى متلازمة لي، وهو مرض تنكس عصبي حاد.
Who should consider this NDUFS3 genetic test?
Individuals with suspected mitochondrial disease, children with developmental regression, ataxia, or elevated lactate, and families with history of Leigh syndrome should undergo testing. الأشخاص المصابون بأمراض الميتوكوندريا المشتبه بها، والأطفال الذين يعانون من تراجع في النمو، أو ترنح، أو ارتفاع اللاكتات، والعائلات التي لديها تاريخ من متلازمة لي.
What does the test result mean for my child’s health?
A positive NDUFS3 mutation confirms Leigh syndrome diagnosis and guides prognosis and family planning; a negative result may require further mitochondrial genome analysis. تؤكد الطفرة الإيجابية في NDUFS3 تشخيص متلازمة لي وتوجه التكهن والتخطيط الأسري؛ وقد تتطلب النتيجة السلبية مزيدًا من تحليل الجينوم الميتوكوندري.
UAE Regulatory Compliance & Data Privacy
This test is performed under clinical license 9834453, adhering to Federal Decree-Law No. 41 of 2024 on Medical Liability (Art. 87), the UAE Child Data Sensitivity (CDS) Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL). All genetic data is encrypted and stored within UAE borders. Home collection services are MOHAP‑licensed and follow ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) cold‑chain protocols.
For requisition or insurance billing verification, WhatsApp: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians